Corporate America a Huge Stumbling Block for China Policy, Hudson Institute Panel Agrees
China can count on Corporate America for huge support on Capitol Hill. And that’s becoming a big problem for policy makers, Hudson Institute says.
China can count on Corporate America for huge support on Capitol Hill. And that’s becoming a big problem for policy makers, Hudson Institute says.
Democratic members of the trade subcommittee at House Ways & Means gets an earful on why ‘de minimis’ should be reformed, or terminated.
China’s offer to help the U.S. fight fentanyl is dubious, a House Foreign Affairs Chairman Says in Latest Hearing.
The House China Select Committee released its 52 page strategy report for 2024. Here’s what’s inside, and what might be missing.
In meeting about the new 2024 strategy report by the House Select Committee on the CCP, disagreements on decoupling, tariffs, and trade with China.
Katherine Tai sticks up for domestic economy in international trade relations during Aspen Security Forum.
In Senate hearing: imported generic drugs facing consistent drug shortages need a government incentive program to help labs make life-saving commodity drugs domestically.
The October trade deficit rose, but the biggest takeaway from the latest data is how much the China goods gap is in decline this year.
A recent study suggests that Americans prefer locally produced medications if they are unclear where the product was made or if the lab has received bad reviews from an FDA inspection.
Big Tech is “big mad” with Biden administration pulling out of WTO digital trade initiative. Why it was a good idea to do so.